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Abstract
High need for effective bone substitutes and drawbacks of the materials approved for clinical
use determine the increasing activity of biomedical research in this area. We have developed
gene-Activated bone substitutes consisting of a scaffold based on octacalcium phosphate (OCP)
and one of the two variants of plasmid DNA carrying either a gene for vascular endothelial
growth factor (VEGF) or two genes encoding VEGF and stromal derived factor- 1α (SDF-1α). The
aim of the study was to evaluate the cytotoxicity of the gene-Activated materials and their
components, as well as biological activity in vitro. We found that both OCP and gene-Activated
bone substitutes did not have any cytotoxicity, but reduced the proliferative activity of human
bone  marrow-derived  multipotent  mesenchymal  stromal  cells:  material  with  doublegene
construct  decreased cell  culture doubling rate of  24.3% more compared with the material
carrying plasmid DNA encoding only VEGF. Both gene-Activated materials led to an increase in
therapeutic genes mRNA levels,  but the material  with double-gene system enhanced VEGF
protein production greater.  Thus, the gene-Activated bone substitutes characterized by the
absence of cytotoxic properties and possessed a specific activity increasing expression of the
therapeutic genes. However, further studies are needed to detail the identified characteristics
and assess the feasibility of the defined biological action in vivo.
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